XML 85 R28.htm IDEA: XBRL DOCUMENT v3.20.1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of the fair value of financial instruments
 
March 31, 2020
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Interest rate derivative agreements (included in Prepaid expenses and other current assets)
$
153

 
$

 
$
153

 
$

Total Assets
$
153

 
$

 
$
153

 
$

Liabilities
 
 
 
 
 

 
 

Tax Receivable Agreement Liability (included in Income tax receivable agreement payable with a portion included in Accrued expenses and other current liabilities)
$
1,300

 
$

 
$

 
$
1,300

Interest rate swap agreement (included in Accrued expense and other current liabilities)
2,235

 

 
2,235

 

Interest rate swap agreement (included in Other long-term liabilities)
632

 

 
632

 

Total Liabilities
$
4,167

 
$

 
$
2,867

 
$
1,300

Temporary Equity
 
 
 
 
 

 
 

Noncontrolling interests subject to put provisions
$
127,737

 
$

 
$

 
$
127,737

 
 
December 31, 2019
 
Total
 
Level 1
 
Level 2
 
Level 3
Assets
 
 
 
 
 
 
 
Interest rate derivative agreements (included in Prepaid expenses and other current assets)
$
143

 
$

 
$
143

 
$

Total Assets
$
143

 
$

 
$
143

 
$

Liabilities
 
 
 
 
 
 
 

Tax Receivable Agreement Liability (included in Income tax receivable agreement payable)
$
3,000

 
$

 
$

 
$
3,000

Interest rate swap agreement (included in Accrued expenses and other current liabilities)
783

 

 
783

 

Interest rate swap agreement (included in Other long-term liabilities)
725

 

 
725

 

Total Liabilities
$
4,508

 
$

 
$
1,508

 
$
3,000

Temporary Equity
 
 
 
 
 
 
 

Noncontrolling interests subject to put provisions
$
126,483

 
$

 
$

 
$
126,483


Fair value rollforward for the Tax receivable agreement liability, which is classified as a Level 3 financial instrument
The following table provides the fair value rollforward for the three months ended March 31, 2020 for the TRA liability, which is classified as a Level 3 financial instrument:
Balance at December 31, 2019
$
3,000

Options exercised and dividend equivalent payment vesting
(1
)
Total realized/unrealized losses:
 
Included in earnings and reported as Change in fair value of income tax receivable agreement
(1,699
)
Balance at March 31, 2020
$
1,300